API Indications APIs Current Stage Target (DMF Registration) Contrast Agent Ioversol Finished R&D, Patent Application 2020.4Q Iomeprol Finished R&D, Patent Application Ready for PV 2026.4Q Antidepressant Escitalopram Oxalate Finished R&D, Patent Application, Ready for PV 2019.4Q Antibiotic Cefmetazole Na(Powder form) Finished R&D, Patent Application, Ready for PV 2020.1Q Flomoxef Na (Powder form) Finished R&D, Patent Application Ready for PV 2026.4Q Multiple Sclerosis Ozanimod R&D 2028.4Q Antibiotic Tigecycline R&D 2028.4Q Autoimmune DiseaseJanus kinase (JAK) inhibitor Upadacitinib R&D 2028.4Q Anticancer Drug Antibody-DrugConjugates(ADC) R&D 2028.4Q Formulation Dosage form Pipeline Items & Plan Injection(Injectable KIT) IR-IV Pain/Inflammation IR-IV complexes Total Parenteral Nutrition NSAIDs-complexes Pre-Filled SyringePFS LA-SC Skin booster Whitening Oral Solid Dosage form(OSDF) ER-GI Extended-release NSAIDs Generic&Modified Drug Gastroesophageal reflux disease ObesityOthers Finished Drug Product Group Item Current Stage Injection Prefilled Syringe Under Development